Oncology & Cancer

A novel oncogenic network specific to liver cancer initiation

Researchers headed by Erwin Wagner, the Director of the BBVA Foundation-CNIO Cancer Cell Biology Programme at the Spanish National Cancer Research Centre (CNIO), have deciphered how a stress-inducible gene regulator, AP-1, ...

Oncology & Cancer

Blocking tumor-induced inflammation impacts cancer development

Researchers at the University of California, San Diego School of Medicine report the discovery of microbial–dependent mechanisms through which some cancers mount an inflammatory response that fuels their development and ...

Medications

Aubagio approved for multiple sclerosis

(HealthDay)—Aubagio (teriflunomide) has been approved by the U.S. Food and Drug Administration to treat adults with relapsing forms of multiple sclerosis (MS).

Genetics

'REST' is crucial for the timing of brain development

Researchers have just shown that the molecule REST acts as an adapter in stem cells, and hope that future studies of REST will contribute to the development of new types of treatments for diseases such as cancer.

Oncology & Cancer

Small molecules can starve cancer cells

All cells in our body have a system that can handle cellular waste and release building blocks for recycling. The underlying mechanism is called autophagy and literally means "self-eating". Many cancer cells have increased ...

page 5 from 6